Related Experiment Video
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Clinical Manifestations
Peter J Morin1, Ying Wang2, Joel Reisman3
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Background:
Alzheimer's disease progression is typically staged using cognitive tests. This study aimed to define clinical stages measured by Instrumental Activities of Daily Living (IADL) using a crosswalk with Montreal Cognitive Assessment (MoCA) scores.
Method:
Patients with mild cognitive impairment (MCI) or Alzheimer's dementia (AD) were identified from the Veteran's Affairs Healthcare System (VAHS) database from 2020 - 2024. Paired MoCA and Lawton-Brody IADL scores were analyzed to generate IADL score means, standard deviations (SD), medians, and ranges. Linear and repeated measures mixed effects analysis was performed adjusting for patient demographics.
Result:
The study sample (N = 1,327) had a mean age of 80.1 years (97.4% men, 18.4% Black, and 12.0% Hispanic). MoCA cut-offs for Normal, MCI, Mild, Moderate, and Severe AD stages were ≥29, 26,18, 11 and ≤10, respectively. Corresponding mean (SD) and median IADL score cutoffs separating disease stages were: normal (n = 14), 7.0 (1.8) and 8; MCI (n = 96), 6.4 (2.3) and 8; mild (n = 666) 5.9 (2.5) and 7; moderate (n = 393) 4.0 (2.9) and 3; severe (n = 158), 2.4 (2.6) and 1. IADL tests resulted in ranges of 3-8 for normal, 1-8 for MCI, and 0-8 for other stages. The IADL linear least squares (LS) means were distributed as >7.6, 6.9-7.6, 5.1-6.9, 3.5-5.1, <3.5 for normal, MCI, mild, moderate, and severe stages projected by MoCA cutoffs, respectively (adjusted R-squared=0.25). The LS means from categorical regression were 7, 6.5, 6.0, 4.2, and 2.6 for normal, MCI, mild, moderate and severe stages, respectively (adjusted R-squared=0.23). Similarly, LS means from repeated measures analysis found IADL score ranges for normal to severe AD were >7.3, 6.7-7.3, 5.1-6.7, 3.6-5.1, and <3.6.
Conclusion:
This study identified IADL score thresholds corresponding to clinical stages from normal to severe AD according to a regressional crosswalk with MoCA. The findings from categorial regression allowed greater spread of the IADL cut-offs from mild to severe AD stages compared to linear and repeated measures regressions, accommodating nonlinearity in the cut-off score distribution.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

